![Dear Freddie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dear Freddie
Private Equity Investor chez
Monograph Capital Advisors (UK) LLP
Profil
Freddie Dear is currently working as a Principal at Monograph Capital Advisors (UK) LLP since 2021.
He is also serving as the Vice President-Corporate Development at Ascend Gene & Cell Therapies Ltd. since 2022.
Previously, Freddie worked as an Operations Director at Quell Therapeutics Ltd. from 2019 to 2020.
He also held the position of Partner at Syncona Partners LLP from 2018 to 2021.
Freddie completed his undergraduate degree from The University of Edinburgh in 2016.
Postes actifs de Dear Freddie
| Sociétés | Poste | Début |
|---|---|---|
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 01/12/2021 |
Ascend Gene & Cell Therapies Ltd.
 Ascend Gene & Cell Therapies Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research and development center | Corporate Officer/Principal | 01/12/2021 |
Anciens postes connus de Dear Freddie
| Sociétés | Poste | Fin |
|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Private Equity Investor | 31/12/2021 |
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and supplies immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases | Directeur des opérations | 31/03/2020 |
Formation de Dear Freddie
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and supplies immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases | Health Technology |
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Finance |
Ascend Gene & Cell Therapies Ltd.
Ascend Gene & Cell Therapies Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research and development center | Commercial Services |
